908 Devices Inc. (MASS) stock

MASSNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3027% above fair value

$9.79−0.27 (-2.68%)

Close on Nov 12, 2026Market cap $404.66MP/E –Yield –

908 Devices ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

908 Devices's ebitda for the twelve months ending Sep 30, 2026 was -$22.97M. For fiscal 2025 it was -$34.96M. The highest annual figure on record is -$4.98M in fiscal 2020.

Annual ebitda

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-$34.96M	–
FY2024	Dec 31, 2024	-$52.71M	–
FY2023	Dec 31, 2023	-$40.37M	–
FY2022	Dec 31, 2022	-$33.77M	–
FY2021	Dec 31, 2021	-$21.14M	–
FY2020	Dec 31, 2020	-$4.98M	–

Quarterly ebitda

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	-$3.98M	–
Q2 FY2026	Jun 30, 2026	-$11.45M	–
Q1 FY2026	Mar 31, 2026	-$11.75M	–
Q4 FY2025	Dec 31, 2025	$4.20M	–
Q3 FY2025	Sep 30, 2025	-$15.23M	–
Q2 FY2025	Jun 30, 2025	-$14.19M	–
Q1 FY2025	Mar 31, 2025	-$9.74M	–
Q4 FY2024	Dec 31, 2024	-$15.31M	–
Q3 FY2024	Sep 30, 2024	-$23.08M	–
Q2 FY2024	Jun 30, 2024	-$8.04M	–
Q1 FY2024	Mar 31, 2024	-$6.28M	–
Q4 FY2023	Dec 31, 2023	-$9.31M	–
Q3 FY2023	Sep 30, 2023	-$8.35M	–
Q2 FY2023	Jun 30, 2023	-$10.33M	–
Q1 FY2023	Mar 31, 2023	-$12.38M	–
Q4 FY2022	Dec 31, 2022	-$9.76M	–
Q3 FY2022	Sep 30, 2022	-$6.70M	–
Q2 FY2022	Jun 30, 2022	-$8.06M	–
Q1 FY2022	Mar 31, 2022	-$9.25M	–
Q4 FY2021	Dec 31, 2021	-$3.24M	–
Q3 FY2021	Sep 30, 2021	-$5.02M	–
Q2 FY2021	Jun 30, 2021	-$7.22M	-409.5%
Q1 FY2021	Mar 31, 2021	-$5.67M	–
Q4 FY2020	Dec 31, 2020	-$3.67M	–
Q3 FY2020	Sep 30, 2020	-$1.09M	–
Q2 FY2020	Jun 30, 2020	$2.33M	–
Q1 FY2020	Mar 31, 2020	-$2.56M	–